Aging pathways are cellular signaling networks that govern the rate of biological decline over time. Scientists study these molecular routes—like insulin/IGF-1 or mTOR—to identify interventions for extending healthspan. Researchers and biotech firms benefit by developing therapies targeting age-related diseases, while individuals gain insights into lifestyle choices that may slow aging.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends